- Trials with a EudraCT protocol (166)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
166 result(s) found for: Female infertility.
Displaying page 1 of 9.
EudraCT Number: 2007-005409-22 | Sponsor Protocol Number: FRAGMIN | Start Date*: 2007-09-03 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA UNIVERSITARIA CAREGGI | |||||||||||||
Full Title: RANDOMIZED MULTICENTER STUDY ON DALTEPARIN TREATMENT IN IVF PATIENTS | |||||||||||||
Medical condition: couple infertility | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-000941-42 | Sponsor Protocol Number: FSD-IEQ-2021-03 | Start Date*: 2021-07-06 | ||||||||||||||||||||||||||||||||||||
Sponsor Name:Fundacion Santiago Dexeus Font | ||||||||||||||||||||||||||||||||||||||
Full Title: The impact of the intensity of ovarian stimulation on embryo quality in predicted suboptimal responders. A randomized controlled trial. | ||||||||||||||||||||||||||||||||||||||
Medical condition: To compare the number of GQB and the morphokinetic parameters of early embryo development in infertile suboptimal patients undergoing two different intensities of ovarian stimulation, a milder appr... | ||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||||||||||||||||||||||
Trial protocol: ES (Ongoing) | ||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-003304-39 | Sponsor Protocol Number: 13.010 | Start Date*: 2014-07-16 | |||||||||||
Sponsor Name:Fertilitycenter Odense | |||||||||||||
Full Title: Assisted reproduction and the early luteal phase The effect of ovulation induction on the endocrine profile | |||||||||||||
Medical condition: Infertility, particularly the luteal phase during IVF | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-004302-33 | Sponsor Protocol Number: TESTOPRIM | Start Date*: 2017-04-07 | |||||||||||
Sponsor Name:INSTITUTO DE INVESTIGACIÓN SANITARIA LA FE | |||||||||||||
Full Title: Clinical effect of follicular preparation with testosterone in poor ovarian response: a randomized controlled clinical trial (TESTOPRIM) | |||||||||||||
Medical condition: Infertility with Poor Ovarian Response | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-000448-13 | Sponsor Protocol Number: Agonist6 | Start Date*: 2014-04-23 | |||||||||||
Sponsor Name:The Fertility Clinic, Skive Regional Hospital | |||||||||||||
Full Title: The exogenous progesterone free luteal phase after GnRHa trigger – a randomized controlled pilot study in high-responder IVF patients | |||||||||||||
Medical condition: Infertility | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-009375-35 | Sponsor Protocol Number: rFSH+rhCG/rFSH+rLH | Start Date*: 2009-06-25 | |||||||||||
Sponsor Name:Regionshospital skive | |||||||||||||
Full Title: Den endokrine effekt af enten r-LH eller lav dosis r-hCG tilskud til r-FSH stimulering hos normogonadotrope kvinder som gennemgår IVF/ICSI behandling efter en lang GnRH agonist nedreguleringsprotocol | |||||||||||||
Medical condition: Fertilitetsbehandling. Sammenligne de endokrine effekter, specielt E2 niveau på hCG dagen hos normogonadatrope IVF/ICSI patienter, som får tilskud af LH aktivitet i form af enten rhCG eller rLH | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-004254-37 | Sponsor Protocol Number: 000400 | Start Date*: 2022-06-27 | |||||||||||
Sponsor Name:Ferring Pharmaceuticals A/S | |||||||||||||
Full Title: A randomised, double-blind, placebo-controlled trial to assess the efficacy and safety of FE 999049 for treatment of men with idiopathic infertility | |||||||||||||
Medical condition: Idiopathic male infertility (including oligoasthenozoospermia) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: SE (Trial now transitioned) DE (Trial now transitioned) ES (Trial now transitioned) DK (Trial now transitioned) BE (Trial now transitioned) IT (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-002218-13 | Sponsor Protocol Number: 25289 | Start Date*: 2004-11-09 | |||||||||||
Sponsor Name:INDUSTRIA FARMACEUTICA SERONO | |||||||||||||
Full Title: A phase III, multicenter, randomized, open, comparative study to evaluate if the addition of r-hLH (Luveris) ti FSH from day 8 of ovarian stimulation is able to decrease total FSH dose and to impro... | |||||||||||||
Medical condition: Reduction of the FSH dose needed to obtain/retrieve each oocyte after administration of Luveris to FSH at day 8 of ovarian stimulation. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-002936-17 | Sponsor Protocol Number: LIV001 | Start Date*: 2019-02-22 |
Sponsor Name:Livio Falun | ||
Full Title: Treatment with intralipid in assisted fertilization | ||
Medical condition: Infertility conditions that required IVF treatment Male infertility Endometrosis PCOS uNEXPLAINED INFERTILITY Tubal damage | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2022-003879-42 | Sponsor Protocol Number: 2021/ABM/03/00006 | Start Date*: 2023-04-12 | ||||||||||||||||
Sponsor Name:Medical Univeristy of Bialystok | ||||||||||||||||||
Full Title: A randomized, controlled, double-blind clinical trial evaluating the effect of METformin treatment on endometrial function in women diagnosed with Idiopathic Infertility | ||||||||||||||||||
Medical condition: Potential causes of idiopathic infertility include in particular: abnormal function of the endometrium, including implantation disorders and immunological abnormalities, genetic abnormalities and t... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: PL (Trial now transitioned) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-003810-13 | Sponsor Protocol Number: 000289 | Start Date*: 2018-05-21 | |||||||||||||||||||||||||||||||
Sponsor Name:Ferring Pharmaceuticals A/S | |||||||||||||||||||||||||||||||||
Full Title: A randomised, double-blind, placebo-controlled, parallel-group, dose-range trial to investigate the efficacy and safety of FE 999302 as add-on treatment to follitropin delta (REKOVELLE) in women un... | |||||||||||||||||||||||||||||||||
Medical condition: Women diagnosed with tubal infertility or unexplained infertility or endometriosis stage I/II or having partners diagnosed with male factor infertility, eligible for IVF and/or ICSI. | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||||||||||||||||||||||
Trial protocol: CZ (Completed) DK (Completed) BE (Completed) GB (GB - no longer in EU/EEA) ES (Completed) | |||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2015-005682-24 | Sponsor Protocol Number: RIOTA2015 | Start Date*: 2016-03-16 | |||||||||||||||||||||
Sponsor Name:Sven Olaf Skouby, Professor, MD, DMSc. Unit of Reproductive Medicine, Herlev/Gentofte Hospital | |||||||||||||||||||||||
Full Title: REDUCING THE IMPACT OF OVARIAN STIMULATION - THE RIOT PROJECT STUDY RIOT A: THE ROLE OF AROMATASE INHIBITOR IN REDUCING THE DETRIMENTAL EFFECTS OF OVARIAN STIMULATION TO OPTIMIZE OUTCOMES IN FRESH... | |||||||||||||||||||||||
Medical condition: Infertility | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||||||||||||
Trial protocol: DK (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-005683-41 | Sponsor Protocol Number: RIOTB2015 | Start Date*: 2016-03-16 | |||||||||||||||||||||
Sponsor Name:Sven O. Skouby, Professor, MD, DMSc. Unit of reproductive Medicine, Herlev/Gentofte Hospital | |||||||||||||||||||||||
Full Title: REDUCING THE IMPACT OF OVARIAN STIMULATION - THE RIOT PROJECT RIOT STUDY B: MAPPING THE ENDOCRINE DETERMINANTS OF OVARIAN STIMULATION TO OPTIMIZE OUTCOMES IN FRESH EMBRYO TRANSFER CYCLES ... | |||||||||||||||||||||||
Medical condition: Infertility | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||||||||||||
Trial protocol: DK (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-023534-23 | Sponsor Protocol Number: EMR 200061-504 | Start Date*: 2011-05-09 | ||||||||||||||||
Sponsor Name:Merck Serono S.A. - Geneva | ||||||||||||||||||
Full Title: A phase IIIB, multicentre, multinational, randomized, open-label trial to compare the efficacy and safety of ovarian stimulation with GONAL-f® day 1 to day 5 followed by Pergoveris® starting day 6 ... | ||||||||||||||||||
Medical condition: Fertility disorders | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: NL (Completed) SK (Completed) DE (Completed) FI (Completed) GB (Completed) DK (Completed) GR (Completed) IT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2016-002321-11 | Sponsor Protocol Number: 2016LAT | Start Date*: 2016-12-27 | |||||||||||
Sponsor Name:Helena Tinkanen, Tampereen yliopistollinen sairaala | |||||||||||||
Full Title: Scientific title: A Protocol for a Randomized, Controlled Study to Compare the Use of Gonodotropin-releasing Hormone Agonist Triptoreline (Gonapeptyl®) for Luteal Phase Support Versus Natural Lutea... | |||||||||||||
Medical condition: | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: FI (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-006514-15 | Sponsor Protocol Number: RD-5103-015-06 | Start Date*: 2007-11-26 | |||||||||||
Sponsor Name:The University of Nottingham [...] | |||||||||||||
Full Title: Double blind crossover randomised controlled trial comparing letrozole versus clomifene citrate for ovulation induction in women with polycystic ovarian syndrome | |||||||||||||
Medical condition: Infertility due to polycycstic ovarian syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-004784-20 | Sponsor Protocol Number: BER-PRO-2014-01 | Start Date*: 2015-01-22 | |||||||||||
Sponsor Name:Instituto Bernabeu | |||||||||||||
Full Title: Subcutaneous progesterone ( Prolutex ) versus vaginal progesterone capsules (Progeffik) for endometrial preparation in fresh donated oocyte recipients: A prospective, randomized, single-blind, pi... | |||||||||||||
Medical condition: Infertility. Assisted Reproductive Techniques. Fresh donated oocyte recipients | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-003006-27 | Sponsor Protocol Number: GEXGP24201 | Start Date*: 2012-11-27 | |||||||||||
Sponsor Name:Glycotope GmbH | |||||||||||||
Full Title: A Phase II, Multicentre, Multinational, Randomised, Assessor-Blind Trial to Investigate the Efficacy and Safety of Various Dosages of FSH-GEX™ in Comparison With 150 IU Gonal-f® in Women Undergoing... | |||||||||||||
Medical condition: women undergoing intracytoplasmatic sperm injection (ICSI) as part of assisted reproduction | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: HU (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-002482-19 | Sponsor Protocol Number: 13EU/FSH01 | Start Date*: 2013-12-12 | |||||||||||
Sponsor Name:IBSA Institut Biochimique S.A. | |||||||||||||
Full Title: Randomised clinical trial comparing highly purified FSH formulation (Fostimon®) and recombinant FSH (Gonal-F®) in GnRH-antagonist controlled ovarian hyperstimulation cycles. | |||||||||||||
Medical condition: female infertility | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: IT (Completed) GB (Completed) ES (Completed) BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-001622-10 | Sponsor Protocol Number: 000048 | Start Date*: 2012-10-08 | |||||||||||
Sponsor Name:Ferring Pharmaceuticals A/S | |||||||||||||
Full Title: A randomised, placebo-controlled, double-blind, parallel groups, multinational, multicentre trial assessing the effect of barusiban administered subcutaneously on the day of transfer on implantatio... | |||||||||||||
Medical condition: Infertility female | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: BE (Completed) CZ (Completed) ES (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
